Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Neuroblastoma 60Central Nervous System Neoplasms 39Brain Neoplasms 34Medulloblastoma 26Astrocytoma 15Rhabdoid Tumor 12Glioblastoma 12Ependymoma 12Sarcoma 10Glioma 9Testicular Neoplasms 8Oligodendroglioma 7Choroid Plexus Neoplasms 7Teratoma 6Optic Nerve Glioma 6Neuroectodermal Tumors, Primitive, Peripheral 6Gliosarcoma 6Testicular Germ Cell Tumor 5Retinoblastoma 5Neuroectodermal Tumors, Primitive 5Neoplasms 5Lymphoma 5Recurrence 4Ovarian Neoplasms 4Ganglioneuroblastoma 4Familial ependymoma 4Carcinoma, Renal Cell 4Spinal Cord Neoplasms 3Rhabdomyosarcoma 3Osteosarcoma 3

Interventions

merphos 1Vincristine 1Methotrexate 1Mental Status and Dementia Tests 1Etoposide 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Basal Cell Nevus Syndrome × Etoposide × CNS × Clear all
NCT02017964 2023-01-09

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Children's Oncology Group

Phase 2 Completed
26 enrolled 14 charts
CNSDermatologic

Basal Cell Nevus Syndrome, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡